Skip to main content

Table 1 Clinical and laboratory variables with follow-up for 1 week

From: A longitudinal study highlights shared aspects of the transcriptomic response to cardiogenic and septic shock

Clinical variableShockT1T2T3p value
Heart rate, bpmCS87 (9)90 (15)92 (23)0.69532
SS91 (22)81 (13)88 (22) 
Systolic blood pressure, mmHgCS84 (11)105 (24)113 (34)0.31639
SS83 (11)97 (16)110 (17) 
Diastolic blood pressure, mmHgCS51 (7)52 (9)63 (17)0.01147
SS45 (4)49 (5)53 (12) 
Mean arterial pressure, mmHgCS61 (6)69 (14)79 (21)0.04505
SS57 (5)64 (7)72 (12) 
Respiratory rate, rpmCS21 (5)26 (7)27 (3)0.82505
SS25 (8)25 (6)27 (8) 
PaO2, mmHgCS92 (44)79 (15)77 (12)0.17879
SS85 (17)76 (18)70 (11) 
PaCO2, mmHgCS35.0 (13.7)39.3 (6.5)38.8 (5.6)0.10633
SS44.1 (13.0)40.3 (8.5)38.5 (6.9) 
SvcO2%CS64 (11)67 (5)86 (7)0.49098
SS73 (6)69 (8)61 (17) 
FiO2CS0.59 (0.30)0.35 (0.08)0.33 (0.08)0.87275
SS0.52 (0.20)0.34 (0.10)0.33 (0.08) 
PaO2/FiO2CS189 (109)239 (70)250 (73)0.51411
SS194 (103)245 (89)229 (64) 
Temperature, °CCS36.7 (1.5)37.3 (0.8)36.7 (1.0)0.01178
SS37.6 (0.9)37.5 (0.9)37.5 (1.3) 
Urine output, mL/dayCS1492 (851)2184 (926)1963 (1323)0.18808
SS1494 (831)2272 (1057)2591 (1219) 
Fluid balance, mLCS1427 (1417)197 (1104)− 17 (1267)0.59677
SS2591 (1958)411 (1529)− 815 (1358) 
HCO3, mmol/LCS18.1 (3.9)26.0 (3.9)27.6 (3.6)0.57272
SS19.8 (3.9)25.1 (4.8)27.0 (5.0) 
Norepinephrine, μg/(kg min)CS0.23 (0.2)0.20 (0.22)0.16 (0.13)0.58250
SS0.35 (0.29)0.23 (0.34)0.05 (0.02) 
Bilirubin, mg/dLCS1.1 (0.6)0.9 (0.4)0.8 (0.6)0.56664
SS1.6 (1.8)1.2 (1.4)1.0 (1.2) 
Glycemia, mg/dLCS218.2 (73.6)146.9 (25.1)140.9 (54.4)0.37518
SS183.9 (84.8)142.8 (37.9)129.8 (34.3) 
Prothrombin time INRCS1.5 (0.8)1.2 (0.5)1.1 (0.1)0.09433
SS1.3 (0.3)1.1 (0.2)1.1 (0.2) 
Fibrinogen, g/LCS4.11 (1.46)4.34 (2.33)7.15 (1.68)0.02844
SS5.32 (2.14)6.35 (2.13)6.81 (1.53) 
CRP value, mg/LCS62.8 (49.3)149.7 (74.8)75.5 (39.2)0.00001
SS248.5 (140.6)248.3 (112.5)120.4 (71.0) 
Creatinine, mg/dLCS1.4 (0.5)1.3 (0.6)1.0 (0.4)0.61095
SS1.9 (1.4)1.4 (1.1)1.1 (0.7) 
Lactate levels, mmol/LCS4.9 (3.6)1.2 (0.4)1.2 (0.5)0.84012
SS4.3 (2.4)1.7 (0.8)1.2 (0.5) 
SOFACS11.0 (2.5)7.5 (2.8)5.2 (3.0)0.36026
SS12.1 (2.0)8.8 (3.0)5.5 (3.3) 
Glasgow Coma ScaleCS6 (4)10 (3)13 (3)0.36746
SS5 (4)9 (3)11 (3) 
Platelets, 103/mm3CS260 (85)208 (80)295 (138)0.16299
SS205 (103)176 (84)235 (107) 
Hematocrit %CS39.2 (4.0)34.9 (4.9)35.2 (4.4)0.00360
SS34.6 (5.0)30.2 (5.2)31.4 (4.4) 
Leukocytes total, 103/mm3CS15.92 (5.36)12.09 (4.20)10.83 (2.93)0.90718
SS16.19 (13.94)14.55 (7.67)13.66 (5.36) 
White blood cells, 109/LCS15.29 (6.00)12.2 (4.61)11.29 (2.95)0.98992
SS15.96 (14.22)14.49 (7.95)13.98 (5.59) 
Lymphocytes, 109/LCS1.41 (0.70)1.37 (0.65)1.54 (0.67)0.00007
SS0.70 (0.60)0.80 (0.54)0.90 (0.47) 
Neutrophils, 109/LCS10.75 (6.27)10.50 (5.95)7.60 (1.38)0.10346
SS14.49 (7.22)11.32 (2.25)12.14 (2.75) 
  1. Clinical and laboratory characteristics of the patients divided by cardiogenic shock (CS) and septic shock (SS). Data are presented as mean (SD). p values were calculated with ANOVA and describe the significance of the difference between the variables in cardiogenic shock and septic shock over the three time points